
Maria Victoria Vanderhorst
Examiner (ID: 15095, Phone: (571)270-3604 , Office: P/3688 )
| Most Active Art Unit | 3688 |
| Art Unit(s) | 4194, 3688, 3682, 3621 |
| Total Applications | 630 |
| Issued Applications | 282 |
| Pending Applications | 54 |
| Abandoned Applications | 311 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1009262
[patent_doc_number] => 06900024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-31
[patent_title] => 'T cell receptor ligands and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 10/193473
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 11830
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/900/06900024.pdf
[firstpage_image] =>[orig_patent_app_number] => 10193473
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/193473 | T cell receptor ligands and methods of using same | Jul 9, 2002 | Issued |
Array
(
[id] => 6258698
[patent_doc_number] => 20020187148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'T cell receptor ligands and methods of using same'
[patent_app_type] => new
[patent_app_number] => 10/193474
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11796
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187148.pdf
[firstpage_image] =>[orig_patent_app_number] => 10193474
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/193474 | T cell receptor ligands and methods of using same | Jul 9, 2002 | Abandoned |
Array
(
[id] => 7440113
[patent_doc_number] => 20040009173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Modulators of leukocyte activation, Hck compositions and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/193720
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31612
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009173.pdf
[firstpage_image] =>[orig_patent_app_number] => 10193720
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/193720 | Modulators of leukocyte activation, Hck compositions and methods of use | Jul 9, 2002 | Issued |
Array
(
[id] => 101811
[patent_doc_number] => 07727731
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-01
[patent_title] => 'Potent, selective and non toxic c-kit inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/482037
[patent_app_country] => US
[patent_app_date] => 2002-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10277
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/727/07727731.pdf
[firstpage_image] =>[orig_patent_app_number] => 10482037
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/482037 | Potent, selective and non toxic c-kit inhibitors | Jun 27, 2002 | Issued |
Array
(
[id] => 540620
[patent_doc_number] => 07169564
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-01-30
[patent_title] => 'FKBP51/52 and CyP40-mediated mammalian hair growth'
[patent_app_type] => utility
[patent_app_number] => 10/178832
[patent_app_country] => US
[patent_app_date] => 2002-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 12759
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/169/07169564.pdf
[firstpage_image] =>[orig_patent_app_number] => 10178832
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/178832 | FKBP51/52 and CyP40-mediated mammalian hair growth | Jun 23, 2002 | Issued |
Array
(
[id] => 6773827
[patent_doc_number] => 20030017165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Chemically programmable immunity'
[patent_app_type] => new
[patent_app_number] => 10/178046
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2585
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017165.pdf
[firstpage_image] =>[orig_patent_app_number] => 10178046
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/178046 | Chemically programmable immunity | Jun 20, 2002 | Abandoned |
Array
(
[id] => 6529451
[patent_doc_number] => 20020192842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Method of treating certain indications associated with hyperglycemia'
[patent_app_type] => new
[patent_app_number] => 10/174883
[patent_app_country] => US
[patent_app_date] => 2002-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17649
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192842.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174883
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174883 | Method of treating certain indications associated with hyperglycemia | Jun 18, 2002 | Abandoned |
Array
(
[id] => 785091
[patent_doc_number] => 06989239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-24
[patent_title] => 'Methods for diagnosis and treatment of chronic immune diseases'
[patent_app_type] => utility
[patent_app_number] => 10/174511
[patent_app_country] => US
[patent_app_date] => 2002-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13648
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/989/06989239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174511
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174511 | Methods for diagnosis and treatment of chronic immune diseases | Jun 16, 2002 | Issued |
Array
(
[id] => 6765631
[patent_doc_number] => 20030100031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Integrative assays for monitoring molecular assembly events'
[patent_app_type] => new
[patent_app_number] => 10/167127
[patent_app_country] => US
[patent_app_date] => 2002-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 27017
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100031.pdf
[firstpage_image] =>[orig_patent_app_number] => 10167127
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/167127 | Integrative assays for monitoring molecular assembly events | Jun 10, 2002 | Abandoned |
Array
(
[id] => 6702368
[patent_doc_number] => 20030225248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => '186 human secreted proteins'
[patent_app_type] => new
[patent_app_number] => 10/164861
[patent_app_country] => US
[patent_app_date] => 2002-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 131941
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20030225248.pdf
[firstpage_image] =>[orig_patent_app_number] => 10164861
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/164861 | 186 human secreted proteins | Jun 9, 2002 | Abandoned |
Array
(
[id] => 6779368
[patent_doc_number] => 20030050450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Methods for purifying highly anionic proteins'
[patent_app_type] => new
[patent_app_number] => 10/163853
[patent_app_country] => US
[patent_app_date] => 2002-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9186
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20030050450.pdf
[firstpage_image] =>[orig_patent_app_number] => 10163853
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/163853 | Methods for purifying Fc-containing proteins | Jun 4, 2002 | Issued |
Array
(
[id] => 6642876
[patent_doc_number] => 20030103995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Detection and therapy of vulnerable plaque with photodynamic compounds'
[patent_app_type] => new
[patent_app_number] => 10/163744
[patent_app_country] => US
[patent_app_date] => 2002-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 23355
[patent_no_of_claims] => 122
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20030103995.pdf
[firstpage_image] =>[orig_patent_app_number] => 10163744
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/163744 | Detection and therapy of vulnerable plaque with photodynamic compounds | Jun 3, 2002 | Abandoned |
Array
(
[id] => 6701105
[patent_doc_number] => 20030223985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Globulin protein to lower cholesterol in humans'
[patent_app_type] => new
[patent_app_number] => 10/157449
[patent_app_country] => US
[patent_app_date] => 2002-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5577
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20030223985.pdf
[firstpage_image] =>[orig_patent_app_number] => 10157449
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/157449 | Globulin protein to lower cholesterol in humans | May 28, 2002 | Abandoned |
Array
(
[id] => 6783702
[patent_doc_number] => 20030065150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Fluorescence-activating antisera and IgG fraction therefrom'
[patent_app_type] => new
[patent_app_number] => 10/151437
[patent_app_country] => US
[patent_app_date] => 2002-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7320
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20030065150.pdf
[firstpage_image] =>[orig_patent_app_number] => 10151437
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/151437 | Fluorescence-activating antisera and IgG fraction therefrom | May 20, 2002 | Issued |
| 10/019139 | Methods and compositions relating to pancreatic islet and beta-cell dysfunction | May 19, 2002 | Abandoned |
Array
(
[id] => 334117
[patent_doc_number] => 07507528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-24
[patent_title] => 'Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells'
[patent_app_type] => utility
[patent_app_number] => 10/488729
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6649
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/507/07507528.pdf
[firstpage_image] =>[orig_patent_app_number] => 10488729
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488729 | Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells | May 16, 2002 | Issued |
Array
(
[id] => 623141
[patent_doc_number] => 07138103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-21
[patent_title] => 'Use of bi-specific antibodies for pre-targeting diagnosis and therapy'
[patent_app_type] => utility
[patent_app_number] => 10/150654
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 41421
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/138/07138103.pdf
[firstpage_image] =>[orig_patent_app_number] => 10150654
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/150654 | Use of bi-specific antibodies for pre-targeting diagnosis and therapy | May 16, 2002 | Issued |
Array
(
[id] => 6750327
[patent_doc_number] => 20030044847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Methods for anlyzing interactions between proteins in live and intact cells'
[patent_app_type] => new
[patent_app_number] => 10/147335
[patent_app_country] => US
[patent_app_date] => 2002-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 29016
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044847.pdf
[firstpage_image] =>[orig_patent_app_number] => 10147335
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/147335 | Methods for anlyzing interactions between proteins in live and intact cells | May 14, 2002 | Abandoned |
Array
(
[id] => 4570031
[patent_doc_number] => 07829289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-09
[patent_title] => 'T cell subpopulation regulating gut immunity'
[patent_app_type] => utility
[patent_app_number] => 10/143822
[patent_app_country] => US
[patent_app_date] => 2002-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 11107
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/829/07829289.pdf
[firstpage_image] =>[orig_patent_app_number] => 10143822
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/143822 | T cell subpopulation regulating gut immunity | May 13, 2002 | Issued |
Array
(
[id] => 6668761
[patent_doc_number] => 20030113744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof'
[patent_app_type] => new
[patent_app_number] => 10/144559
[patent_app_country] => US
[patent_app_date] => 2002-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 41332
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10144559
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/144559 | Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof | May 12, 2002 | Abandoned |